Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/17919
Title: | An official European Respiratory Society statement on physical activity in COPD | Authors: | Watz, Henrik Pitta, Fabio Rochester, Carolyn L. Garcia-Aymerich, Judith ZuWallack, Richard Troosters, Thierry Vaes, Anouk W. Puhan, Milo A. Jehn, Melissa Polkey, Michael I. Vogiatzis, Ioannis Clini, Enrico M. Toth, Michael Gimeno-Santos, Elena Waschki, Benjamin Esteban, Cristobal Hayot, Maurice Casaburi, Richard Porszasz, Janos McAuley, Edward Singh, Sally J. Langer, Daniel Wouters, Emiel F.M. Magnussen, Helgo SPRUIT, Martijn A. |
Issue Date: | 2014 | Source: | EUROPEAN RESPIRATORY JOURNAL, 44 (6), p. 1521-1537 | Abstract: | This European Respiratory Society (ERS) statement provides a comprehensive overview on physical activity in patients with chronic obstructive pulmonary disease (COPD). A multidisciplinary Task Force of experts representing the ERS Scientific Group 01.02 “Rehabilitation and Chronic Care” determined the overall scope of this statement through consensus. Focused literature reviews were conducted in key topic areas and the final content of this Statement was agreed upon by all members. The current knowledge regarding physical activity in COPD is presented, including the definition of physical activity, the consequences of physical inactivity on lung function decline and COPD incidence, physical activity assessment, prevalence of physical inactivity in COPD, clinical correlates of physical activity, effects of physical inactivity on hospitalisations and mortality, and treatment strategies to improve physical activity in patients with COPD. This Task Force identified multiple major areas of research that need to be addressed further in the coming years. These include, but are not limited to, the disease-modifying potential of increased physical activity, and to further understand how improvements in exercise capacity, dyspnoea and self-efficacy following interventions may translate into increased physical activity. The Task Force recommends that this ERS statement should be reviewed periodically (e.g. every 5–8 years). | Notes: | Correspondence: Henrik Watz, Pulmonary Research Institute at LungenClinic Grosshansdorf, Woehrendamm 80, D-22927 Grosshansdorf, Germany. E-mail: h.watz@pulmoresearch.de. | Document URI: | http://hdl.handle.net/1942/17919 | Link to publication/dataset: | http://erj.ersjournals.com/content/44/6/1521.long | ISSN: | 0903-1936 | e-ISSN: | 1399-3003 | DOI: | 10.1183/09031936.00046814 | ISI #: | 000347267500015 | Rights: | Copyright © ERS 2014. | Category: | A1 | Type: | Journal Contribution | Validations: | ecoom 2016 |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
1521.full.pdf | Published version | 426.62 kB | Adobe PDF | View/Open |
SCOPUSTM
Citations
230
checked on Sep 3, 2020
WEB OF SCIENCETM
Citations
342
checked on Apr 22, 2024
Page view(s)
108
checked on Sep 7, 2022
Download(s)
162
checked on Sep 7, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.